COST MINIMIZATION ANALYSIS OF EMICIZUMAB IN THE PROPHYLAXIS OF INHIBITOR-NEGATIVE PATIENTS WITH HEMOPHILIA A IN TURKEY

dc.contributor.authorGuler, B.
dc.contributor.authorOksuz, E.
dc.contributor.authorMalhan, S.
dc.contributor.authorYanik, L.
dc.contributor.authorKoc, E.
dc.contributor.orcID0000-0002-5723-5965en_US
dc.contributor.researcherIDK-8238-2012en_US
dc.date.accessioned2020-10-01T07:34:33Z
dc.date.available2020-10-01T07:34:33Z
dc.date.issued2019
dc.identifier.endpageS851en_US
dc.identifier.issn1098-3015en_US
dc.identifier.startpageS851en_US
dc.identifier.urihttp://hdl.handle.net/11727/4813
dc.identifier.volume22en_US
dc.identifier.wos000503167003155en_US
dc.language.isoengen_US
dc.relation.journalVALUE IN HEALTHen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.titleCOST MINIMIZATION ANALYSIS OF EMICIZUMAB IN THE PROPHYLAXIS OF INHIBITOR-NEGATIVE PATIENTS WITH HEMOPHILIA A IN TURKEYen_US
dc.typeconferenceObjecten_US

Files

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: